LianBio — Form D
LianBio of GRAND CAYMAN, E9, a company, filed a Form D exempt-offering notice with the SEC on 2020-11-12. The offering totals $310.0M, of which $270.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-11-12
- Form: D
- Accession: 0001831283-20-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $310.0M
- Amount sold: $270.0M
- Remaining: $40.0M
- Investors: 23
- Date of first sale: 2020-10-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-380314
Issuer
- Name: LianBio
- CIK: 0001831283
- Entity type: Other
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2019
- Address: C/O OGIER GLOBAL (CAYMAN) LIMITED, GRAND CAYMAN, E9, KY1-9009
- Phone: 1 345 949 9876
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| TASSOS LEO GIANAKAKOS | Director | GRAND CAYMAN, E9 |
| BING LEO LI | Director | GRAND CAYMAN, E9 |
| BING LEO LI | Executive Officer | GRAND CAYMAN, E9 |
| DEBRA LEO YU | Executive Officer | GRAND CAYMAN, E9 |
| Konstantin Poukalov | Director | Marlton, NJ |
| DEBRA ANASTASIOS YU | Executive Officer | GRAND CAYMAN, E9 |
| NEIL LEO KUMAR | Director | GRAND CAYMAN, E9 |
| ADAM LEO STONE | Director | GRAND CAYMAN, E9 |
| TOM ANASTASIOS GIANNAKAKOS | Director | GRAND CAYMAN, E9 |
Other filings by this issuer (1)
More